Publications by authors named "Asma AlJaberi"
Article Synopsis
- - Three young women with generalized body pain were initially diagnosed with fibromyalgia after visiting various specialists, but their symptoms pointed to something more serious.
- - The patients exhibited additional clinical issues such as fractures and hypertension, leading rheumatologists to investigate potential underlying endocrine problems.
- - Further evaluations determined that two patients had adrenal adenoma and one had developed Cushing's syndrome due to corticosteroid use, highlighting the importance of comprehensive assessments beyond a fibromyalgia diagnosis.
Purpose: Patients with hyperlipidemia treated with statins remain at a residual cardiovascular (CV) risk. Omega-3 polyunsaturated fatty acids hold the potential to mitigate the residual CV risk in statin-treated patients, with persistently elevated triglyceride (TG) levels.
Method: We reviewed the current evidence on the use of icosapent ethyl (IPE), an omega-3 fatty acid yielding a pure form of eicosapentaenoic acid.
Romosozumab is a humanized monoclonal antibody that targets the sclerostin protein, which regulates bone formation and resorption. It is a novel therapy in the treatment of post-menopausal women with osteoporosis. The evidence regarding romosozumab's cardiovascular safety is conflicting.
View Article and Find Full Text PDF